Tag Archives: HEIDELBERG

10Apr/13

Lipid Therapeutics Successful Therapy for Ulcerative Colitis

Lipid Therapeutics Successfully Files a US IND for LT-02, a Novel Barrier Function Therapy for Ulcerative Colitis HEIDELBERG, Germany, April 10, 2013 /PRNewswire/ — IND paves the way for the US elementRead More…